|Day Low/High||14.97 / 15.34|
|52 Wk Low/High||10.01 / 24.93|
First-Ever Phase 3 Choroideremia Gene Therapy Trial
Nightstar Therapeutics plc ("Nightstar" or the "Company"), a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, today announced the pricing of its initial public offering in the...
Houlihan Lokey, an international investment bank, today announced a joint marketing alliance with Knight Capital Group, Inc.
These stocks, including News Corp. and Royal Bank of Scotland, could be staging a technical move.
Guests include Matthew Buckley, TheStreet.com contributor and options specialist, Ken Shreve, TheStreet.com's Market Movers portfolio manager and Tim Holland, co-manager for the Aston/Tamro Capital Partners Fund.
The chatter about a hookup between E*Trade and TD Ameritrade heated up again earlier this month, but Raymond James isn't buying it.
Sector Snap: Goldman downgrades Jefferies, upgrades Nasdaq in update on financial sector
Cramer says he would be a buyer at under $6 a share.
Cramer lays out a strategy for investors to go bargain hunting during a holiday-shortened week.
Here's how some of Monday's 'Mad Money' stocks fared on Tuesday.
Cramer says he doesn't understand why the stock is up when the fundamentals are bad.
Cramer says the Fed chairman's speech today showed once again he knows what it takes to get the economy to recover.
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
Federated Investors, Peet's Coffee and Carbo Ceramics were featured in 'Under the Radar' this week.
Knight Capital Group says 3Q profit falls 19 pct, misses Street view; stock drops
Federated Investors, Knight Capital and W.P. Carey lend exposure to financial services without the travails of the loan-heavy behemoths.
Shares of exchanges fall as analyst predicts increased competition, issues downgrades
Lance, Teva Pharmaceuticals, NCI, Emergency Medical Services and Knight Capital are 'buy'-rated stocks.
Lance, Teva Pharmaceuticals, NCI, Bio-Reference Labs and Knight Capital are 'buy' rated stocks.
Lance and Teva are among fast-growth stocks that receive 'buy' recommendations from TheStreet.com.
Here's how some of Wednesday's 'Mad Money' stocks fared on Thursday.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.